These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18322397)

  • 1. Polymorphisms at the paraoxonase 1 L55M and Q192R loci affect the pathophysiology of Alzheimer's disease: emphasis on the cholinergic system and beta-amyloid levels.
    Leduc V; Poirier J
    Neurodegener Dis; 2008; 5(3-4):225-7. PubMed ID: 18322397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of paraoxonase 1 genetic variants in Alzheimer's disease neuropathology.
    Leduc V; Théroux L; Dea D; Robitaille Y; Poirier J
    Eur J Neurosci; 2009 Nov; 30(9):1823-30. PubMed ID: 19863653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
    Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of an association between Paraoxonase 1 gene polymorphisms (Q192R, L55M) and Alzheimer's disease: a meta-analysis.
    Pi Y; Zhang L; Chang K; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
    Neurosci Lett; 2012 Aug; 523(2):174-9. PubMed ID: 22776645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
    Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T
    Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.
    Wills AM; Landers JE; Zhang H; Richter RJ; Caraganis AJ; Cudkowicz ME; Furlong CE; Brown RH
    Neurology; 2008 Mar; 70(12):929-34. PubMed ID: 18347314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of pon1 and pon2 genes in hemodialyzed patients.
    Rajković MG; Barišić K; Juretić D; Grubišić TŽ; Flegar-Meštrić Z; Rumora L
    Clin Biochem; 2011 Aug; 44(12):964-8. PubMed ID: 21620813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human paraoxonase gene polymorphisms and coronary artery disease risk.
    Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA
    Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gln192Arg polymorphism in paraoxonase 1 gene is associated with Alzheimer disease in a Chinese Han ethnic population.
    He XM; Zhang ZX; Zhang JW; Zhou YT; Tang MN; Wu CB; Hong Z
    Chin Med J (Engl); 2006 Jul; 119(14):1204-9. PubMed ID: 16863614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gln192Arg polymorphism of the paraoxonase-1 gene is not associated with Alzheimer's disease in Chinese].
    Shi JJ; Zhang SZ; Ma C; Tang MN; Liu XH; Wang YC; Han HY; Guo YB; Feng RM; Miao GD
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Apr; 24(4):371-4. PubMed ID: 15090300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness to cholinesterase inhibitors in Alzheimer's disease: a possible role for the 192 Q/R polymorphism of the PON-1 gene.
    Pola R; Flex A; Ciaburri M; Rovella E; Valiani A; Reali G; Silveri MC; Bernabei R
    Neurosci Lett; 2005 Jul; 382(3):338-41. PubMed ID: 15925115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PON1 activity and genotype in patients with arterial ischemic stroke and in healthy individuals.
    Schiavon R; Turazzini M; De Fanti E; Battaglia P; Targa L; Del Colle R; Fasolin A; Silvestri M; Biasioli S; Guidi G
    Acta Neurol Scand; 2007 Jul; 116(1):26-30. PubMed ID: 17587252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMP-2, -3 and -9 levels and activity are not related to Abeta load in the frontal cortex in Alzheimer's disease.
    Baig S; Kehoe PG; Love S
    Neuropathol Appl Neurobiol; 2008 Apr; 34(2):205-15. PubMed ID: 17971072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation at the paraoxonase gene locus contributes to carotid arterial wall thickness in subjects with familial hypercholesterolemia.
    Roest M; Jansen AC; Barendrecht A; Leus FR; Kastelein JJ; Voorbij HA
    Clin Biochem; 2005 Feb; 38(2):123-7. PubMed ID: 15642273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.
    Kovács TJ; Harris S; Vas TK; Seres I; Short CD; Wittmann IK; Paragh G; Mackness MI; Mackness B; Durrington PN; Nagy JM; Brenchley PE
    J Nephrol; 2006; 19(6):732-8. PubMed ID: 17173245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase 1 gene polymorphisms do not influence the response to treatment in Alzheimer's disease.
    Klimkowicz-Mrowiec A; Marona M; Spisak K; Jagiella J; Wolkow P; Szczudlik A; Slowik A
    Dement Geriatr Cogn Disord; 2011; 32(1):26-31. PubMed ID: 21829028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase gene polymorphism and the risk for Alzheimer's disease in the polish population.
    Klimkowicz-Mrowiec A; Marona M; Wolkow P; Witkowski A; Maruszak A; Styczynska M; Barcikowska M; Szczudlik A; Slowik A
    Dement Geriatr Cogn Disord; 2011; 31(6):417-23. PubMed ID: 21757906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating paraoxonase-1 gene Q192R and L55M polymorphism in patients with renal cell cancer.
    Uyar OA; Kara M; Erol D; Ardicoglu A; Yuce H
    Genet Mol Res; 2011 Feb; 10(1):133-9. PubMed ID: 21308654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polymorphism in lipoprotein lipase affects the severity of Alzheimer's disease pathophysiology.
    Blain JF; Aumont N; Théroux L; Dea D; Poirier J
    Eur J Neurosci; 2006 Sep; 24(5):1245-51. PubMed ID: 16965549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of paraoxonase 1 (PON1) in organophosphate metabolism: implications in neurodegenerative diseases.
    Androutsopoulos VP; Kanavouras K; Tsatsakis AM
    Toxicol Appl Pharmacol; 2011 Nov; 256(3):418-24. PubMed ID: 21864557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.